Sociedad Americana de Hirudoterapia

Molecular detection of Bartonella spp. in terrestrial leeches feeding on human and animal blood in Gageo-do, Republic of Korea

Zoonotic vector study published in Parasites & Vectors (2016)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportSeguridad y control de infeccionesKang JG et al. · Parasites & vectors, 2016

Abstract

BACKGROUND: Leeches can transmit pathogens and are therefore potentially hazardous to human and animal health. However, only a few studies of diseases transmitted by land leeches have been reported. The purpose of the present study was to analyse which pathogens are carried in Haemadipsa rjukjuana, the first recorded sanguivorous land leech in the Republic of Korea (ROK). FINDINGS: A total of 173 H. rjukjuana were collected from Mt. Dock-Sil on Gageo-do Island, ROK during July 2011. Conventional PCR was conducted for analysis of the origin of blood meal, as well as for detection of species of Anaplasma, Bartonella, Borrelia, Ehrlichia, Rickettsia, and Wolbachia in the leech specimens. Bartonella DNA was detected in eight of the specimens studied based on partial ITS sequence analysis. Seven of the DNA samples were closely related to Bartonella grahamii (99.6-100 % similarity), and one sample exhibited a 90.6 % similarity with Bartonella sp. from Taiwan. Sequences of the mitochondrial cytochrome b gene were generated for a total of 35 of the 173 leech internal organ samples. These included sequences of human (n = 10), mouse (n = 8), weasel (n = 6) and bird (n = 11) origin. Of these 35 sequences, 68.5 % were from mammals, including humans, and 31.4 % were from migratory birds that pass through Gageo-do, ROK. CONCLUSIONS: Although the present study does not provide evidence that leeches indeed transmit Bartonella species to hosts directly, to our knowledge this is the first report on Bartonella DNA being detected from leeches. Therefore, further studies are needed to explore the possibility of zoonotic pathogen transmission by land leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsBartonellaBirdsDNA, BacterialDNA, IntergenicFeeding BehaviorGenotypeHumansIslandsLeechesMiceMustelidae

Resumen

First molecular detection of Bartonella spp. DNA in terrestrial leeches (Haemadipsa rjukjuana) feeding on human and animal blood — flags potential zoonotic vector role.

Por qué esto importa para la hirudoterapia

This study used conventional PCR to screen 173 Haemadipsa rjukjuana terrestrial leeches from Gageo-do Island, Republic of Korea, for vector-borne pathogens, detecting Bartonella DNA in eight specimens (seven closely related to B. grahamii) and identifying blood-meal origins including human, mouse, weasel, and bird via cytochrome b sequencing. For ASH, the study carries indirect safety-relevant implications: it documents potential pathogen carriage by sanguivorous leeches, a consideration for any therapeutic or field context involving leech–host contact. The authors explicitly state that the study provides no evidence of actual Bartonella transmission by leeches to hosts, and no medicinal leech species or hirudotherapy practice is involved. Findings are preliminary and require further investigation of zoonotic transmission risk.

Citación

Molecular detection of Bartonella spp. in terrestrial leeches feeding on human and animal blood in Gageo-do, Republic of Korea.

Kang JG et al. · Parasites & vectors, 2016

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.